DE602004026173D1 - Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln - Google Patents
Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimittelnInfo
- Publication number
- DE602004026173D1 DE602004026173D1 DE602004026173T DE602004026173T DE602004026173D1 DE 602004026173 D1 DE602004026173 D1 DE 602004026173D1 DE 602004026173 T DE602004026173 T DE 602004026173T DE 602004026173 T DE602004026173 T DE 602004026173T DE 602004026173 D1 DE602004026173 D1 DE 602004026173D1
- Authority
- DE
- Germany
- Prior art keywords
- devices
- delayed release
- delivery device
- menopausal
- drug delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
- A61F6/142—Wirelike structures, e.g. loops, rings, spirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46631803P | 2003-04-29 | 2003-04-29 | |
US47357903P | 2003-05-27 | 2003-05-27 | |
PCT/US2004/013172 WO2004096151A2 (en) | 2003-04-29 | 2004-04-29 | Methods and devices for the sustained release of multiple drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004026173D1 true DE602004026173D1 (de) | 2010-05-06 |
Family
ID=33423604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004026173T Active DE602004026173D1 (de) | 2003-04-29 | 2004-04-29 | Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln |
Country Status (8)
Country | Link |
---|---|
US (7) | US7833545B2 (de) |
EP (1) | EP1620060B1 (de) |
JP (1) | JP4898431B2 (de) |
AT (1) | ATE461681T1 (de) |
AU (1) | AU2004233997C1 (de) |
CA (1) | CA2523859C (de) |
DE (1) | DE602004026173D1 (de) |
WO (1) | WO2004096151A2 (de) |
Families Citing this family (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6764505B1 (en) | 2001-04-12 | 2004-07-20 | Advanced Cardiovascular Systems, Inc. | Variable surface area stent |
GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
US7169178B1 (en) * | 2002-11-12 | 2007-01-30 | Advanced Cardiovascular Systems, Inc. | Stent with drug coating |
SG146638A1 (en) | 2003-09-19 | 2008-10-30 | Drugtech Corp | Pharmaceutical delivery system |
DK1768625T3 (da) | 2004-07-09 | 2011-05-09 | Population Council Inc | Sammensætninger med vedvarende frigørelse indeholdende progesteron-receptormodulatorer |
GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
US8057817B2 (en) * | 2004-12-14 | 2011-11-15 | Poly-Med, Inc. | Intravaginal ringed mesh device and applicator therefor |
US9693953B2 (en) | 2006-06-02 | 2017-07-04 | Janet A. Chollet | Method of treating atrophic vaginitis |
GB0613333D0 (en) | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
GB0613638D0 (en) | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
BRPI0713203A2 (pt) * | 2006-07-12 | 2012-04-03 | Controlled Therapeutics Scotland Ltda | inserto, métodos, embalagem, dispositivo recuperável e dispositivo inserìvel |
GB0620685D0 (en) | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
CA2672602C (en) | 2006-12-18 | 2014-05-20 | Electronic Dietary Foods Inc. | Device for delivery of a substance |
WO2009061569A1 (en) * | 2007-11-05 | 2009-05-14 | Repros Therapeutics Inc. | Compositions and methods for treating dysfunctional uterine bleeding |
EP2057972A1 (de) * | 2007-11-07 | 2009-05-13 | N.V. Organon | Intrauterine Vorrichtung |
EP2062568A1 (de) * | 2007-11-22 | 2009-05-27 | Bayer Schering Pharma Oy | System zur vaginalen Freisetzung |
DK2062569T3 (da) * | 2007-11-22 | 2011-08-29 | Bayer Oy | Vaginalt afgivelsessystem |
DK2359807T3 (en) * | 2008-02-04 | 2017-10-16 | Ferring Bv | Monolithic vaginal rings comprising progesterone and methods of preparation and use thereof |
WO2009129459A1 (en) * | 2008-04-18 | 2009-10-22 | Combinent Biomedical Systems, Inc. | Devices that include ethylene-vinyl acetate copolymers and methods of making and using same |
TWI477276B (zh) | 2008-04-28 | 2015-03-21 | Repros Therapeutics Inc | 抗黃體素給藥方案 |
US9034365B2 (en) | 2008-05-20 | 2015-05-19 | Poly-Med, Inc. | Biostable, multipurpose, microbicidal intravaginal devices |
EP2140860A1 (de) | 2008-07-03 | 2010-01-06 | Bayer Schering Pharma Oy | Verbessertes Verhütungsverfahren |
US20100040671A1 (en) * | 2008-08-12 | 2010-02-18 | Ahmed Salah U | Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof |
EP2352544A4 (de) * | 2008-11-07 | 2013-12-25 | Combinent Biomedical Systems Inc | Vorrichtungen und verfahren zur behandlung und/oder vorbeugung von erkrankungen |
FI121000B (fi) * | 2008-11-19 | 2010-06-15 | Bayer Schering Pharma Oy | Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi |
US8568374B2 (en) * | 2009-05-04 | 2013-10-29 | Merck Sharp & Dohme B.V. | Intrauterine system |
JP5695035B2 (ja) | 2009-06-03 | 2015-04-01 | フォーサイト・ビジョン5・インコーポレイテッドForsight Vision5,Inc. | 前眼部薬物供給 |
JP5690826B2 (ja) | 2009-07-21 | 2015-03-25 | ザ・ポピュレイション・カウンシル,インコーポレイテッド | 多層状勾配膣リング |
JP5913136B2 (ja) * | 2010-02-08 | 2016-04-27 | プレーリー ファーマシューティカルズ、エルエルシー | 糖質コルチコイド感作物質としてのプロゲストーゲンの使用方法 |
CA2798034A1 (en) | 2010-03-28 | 2011-10-13 | Evestra, Inc. | Intravaginal drug delivery device |
WO2011146483A1 (en) | 2010-05-17 | 2011-11-24 | Aerie Pharmaceuticals, Inc. | Drug delivery devices for delivery of ocular therapeutic agents |
CN103179926A (zh) * | 2010-06-22 | 2013-06-26 | 特卫华妇女健康有限公司 | 包含抗胆碱剂的阴道内装置及其制备方法 |
US8580294B2 (en) | 2010-10-19 | 2013-11-12 | International Partnership For Microbicides | Platinum-catalyzed intravaginal rings |
AU2011325975B2 (en) * | 2010-11-12 | 2015-11-26 | The University Of Utah Research Foundation | Intravaginal devices for controlled delivery of lubricants |
KR101263916B1 (ko) | 2011-01-11 | 2013-05-13 | 이장희 | 성 호르몬 방출 장치 및 이를 이용한 동물 피임 및 발정 유도 방법 |
DE202012012713U1 (de) * | 2011-03-04 | 2014-01-23 | Arstat, Inc. | Intravaginale Arzneimittelabgabevorrichtung |
US9168303B2 (en) | 2011-07-15 | 2015-10-27 | Universiteit Gent | Intravaginal delivery system |
EP2755634A4 (de) * | 2011-09-14 | 2015-06-10 | Royer Biomedical Inc | Bioresorbierbare arzneimittelfreisetzende matrizen auf basis vernetzter polysaccharide und dosierungsformen davon für verzögerte/gesteuerte wirkstoffabgabe |
CA2848397C (en) | 2011-09-14 | 2022-04-26 | Forsight Vision5, Inc. | Ocular insert apparatus and methods |
PL2782584T3 (pl) | 2011-11-23 | 2021-12-13 | Therapeuticsmd, Inc. | Naturalne skojarzone hormonalne formulacje i terapie zastępcze |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130166931A1 (en) * | 2011-12-23 | 2013-06-27 | Lsi Corporation | Reducing power consumption of memory |
CN103040090B (zh) * | 2012-01-20 | 2016-03-30 | 奥驰亚客户服务公司 | 脱除烟草的口腔用产品 |
CN102754907B (zh) | 2012-01-20 | 2015-06-24 | 奥驰亚客户服务公司 | 口腔用产品 |
CN103039688B (zh) | 2012-01-20 | 2016-01-06 | 奥驰亚客户服务公司 | 口腔用产品 |
CN102754908B (zh) | 2012-01-20 | 2015-06-10 | 奥驰亚客户服务公司 | 口腔用烟草产品 |
US9854831B2 (en) | 2012-01-20 | 2018-01-02 | Altria Client Services Llc | Oral product |
DE102012009057A1 (de) * | 2012-05-09 | 2013-11-14 | Dr. Arabin GmbH & Co. KG | Rotationspessar mit zusätzlicher Wirkstoffkomponente |
SG11201407397WA (en) | 2012-05-31 | 2014-12-30 | Repros Therapeutics Inc | Formulations and methods for vaginal delivery of antiprogestins |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
HUE046128T2 (hu) | 2012-10-26 | 2020-02-28 | Forsight Vision5 Inc | Szemészeti rendszer gyógyszer szembe való késleltetett kibocsátására |
WO2014070517A1 (en) | 2012-11-02 | 2014-05-08 | Repros Therapeutics Inc. | Methods and compositions for treating progesterone-dependent conditions |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10137031B2 (en) | 2013-11-14 | 2018-11-27 | International Partnership For Microbicides, Inc. | Combination therapy intravaginal rings |
US10206932B2 (en) | 2014-05-22 | 2019-02-19 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US9820994B2 (en) | 2014-06-28 | 2017-11-21 | Laboratorios Andromaco S.A. | Cerclage pessary containing progesterone of prolonged, sustained, and continuous release useful for prevention of preterm birth |
CN105277633B (zh) * | 2014-07-26 | 2017-06-23 | 浙江仙琚制药股份有限公司 | 一种炔诺酮衍生物及其中间体的杂质检测分析方法 |
WO2016018993A1 (en) | 2014-07-29 | 2016-02-04 | Therapeuticsmd, Inc. | Transdermal cream |
AR101476A1 (es) | 2014-08-07 | 2016-12-21 | Acerta Pharma Bv | Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk) |
EP3017809A1 (de) | 2014-11-07 | 2016-05-11 | Ferring B.V. | Arzneimittelvorrichtung mit Quinagolid |
HUE046267T2 (hu) | 2015-01-21 | 2020-02-28 | Bayer Oy | Nem szteroid gyulladáscsökkentõ (NSAID) és progesztogén vegyületet tartalmazó gyógyszerbeviteli rendszer és elõállítási eljárások |
CN117298424A (zh) * | 2015-01-30 | 2023-12-29 | 里加利私人有限公司 | 阴道药物递送装置 |
WO2016168141A1 (en) | 2015-04-13 | 2016-10-20 | Forsight Vision5, Inc. | Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent |
JP6898856B2 (ja) * | 2015-05-13 | 2021-07-07 | バイエル・オーイュー | 長時間作用型薬物送達装置および避妊におけるその使用 |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
GB201517523D0 (en) * | 2015-10-05 | 2015-11-18 | Ostara Biomedical Ltd | Methods and compositions for managing reproduction |
US20190008804A1 (en) * | 2016-01-12 | 2019-01-10 | Repros Therapeutics Inc. | Trans-Clomiphene and Progesterone Receptor Antagonist Combination Therapy for Treating Hormone-Dependent Conditions |
WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
AU2017239645A1 (en) | 2016-04-01 | 2018-10-18 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
GB201708224D0 (en) | 2017-05-23 | 2017-07-05 | Juniper Pharmaceuticals Uk Ltd | Device |
FR3070619A1 (fr) * | 2017-09-01 | 2019-03-08 | Ab7 Innovation | Piece moulee monolithique en matrice multiple pour la diffusion d’actifs et son procede d’obtention |
WO2019084469A1 (en) | 2017-10-27 | 2019-05-02 | Renovia Inc. | DEVICES, SYSTEMS, AND METHODS FOR PELVIC FLOOR MUSCLE TRAINING |
CN108186553B (zh) * | 2018-02-13 | 2020-10-02 | 广东药科大学 | 一种黄体酮长效栓剂及其制备方法 |
CN111971039A (zh) * | 2018-04-10 | 2020-11-20 | 里加利私人有限公司 | 阴道全身药物递送 |
AU2019261454A1 (en) * | 2018-04-27 | 2020-12-03 | Evestra, Inc. | Estrogen prodrugs and methods of administering estrogen prodrugs |
EP3801462A4 (de) | 2018-05-24 | 2022-03-16 | Celanese EVA Performance Polymers LLC | Implantierbare vorrichtung zur verzögerten freisetzung einer makromolekularen wirkstoffverbindung |
KR20210013089A (ko) | 2018-05-24 | 2021-02-03 | 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 | 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치 |
EP3952802A4 (de) * | 2019-03-29 | 2023-01-04 | Martell, Bridget | Segmentierte eva-intravaginale ringe |
CN113164383B (zh) * | 2019-10-12 | 2022-08-12 | 国家卫生健康委科学技术研究所 | 用于黄体支持的阴道缓释给药系统及其制备方法与应用 |
FR3107203B1 (fr) * | 2020-02-14 | 2023-11-24 | Ab7 Innovation | Matrice solide composite pour la délivrance prolongée d’actifs |
USD935018S1 (en) * | 2020-04-07 | 2021-11-02 | The Population Council, Inc. | Contraceptive |
WO2023031218A1 (en) | 2021-08-31 | 2023-03-09 | Ferring B.V. | Diagnosis and treatment of ectopic endometriosis |
Family Cites Families (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1945275U (de) * | 1965-04-30 | 1966-09-01 | Ortho Pharma Corp | Intrauterine vorrichtung zur empfaengnisverhuetung. |
US3454004A (en) * | 1967-08-18 | 1969-07-08 | Holland Rantos Co Inc | Intrauterine contraceptive device |
US3545439A (en) | 1968-01-04 | 1970-12-08 | Upjohn Co | Medicated devices and methods |
NL6903028A (de) | 1969-02-26 | 1970-08-28 | ||
US4069307A (en) * | 1970-10-01 | 1978-01-17 | Alza Corporation | Drug-delivery device comprising certain polymeric materials for controlled release of drug |
US3903880A (en) | 1972-08-17 | 1975-09-09 | Alza Corp | Intrauterine device for managing the reproductive process |
US3920805A (en) | 1971-12-09 | 1975-11-18 | Upjohn Co | Pharmaceutical devices and method |
US3938515A (en) | 1971-12-20 | 1976-02-17 | Alza Corporation | Novel drug permeable wall |
US3708511A (en) | 1972-01-18 | 1973-01-02 | Organon | Novel {66 -steroids of the oestrane series |
NL7204025A (de) | 1972-03-24 | 1973-09-26 | ||
US3780935A (en) | 1972-07-10 | 1973-12-25 | Lukacs & Jacoby Ass | Serum separating method |
NL7210262A (de) | 1972-07-26 | 1974-01-29 | ||
US4016251A (en) * | 1972-08-17 | 1977-04-05 | Alza Corporation | Vaginal drug dispensing device |
US3963119A (en) | 1973-10-13 | 1976-06-15 | Lucaks And Jacoby Associates | Serum separating apparatus |
US4043928A (en) | 1973-10-31 | 1977-08-23 | Lukacs And Jacoby Associates | Serum separating composition of matter |
US4155991A (en) * | 1974-10-18 | 1979-05-22 | Schering Aktiengesellschaft | Vaginal ring |
IL48277A (en) | 1974-10-18 | 1978-03-10 | Schering Ag | Vaginal ring |
US4093709A (en) | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
US4144317A (en) * | 1975-05-30 | 1979-03-13 | Alza Corporation | Device consisting of copolymer having acetoxy groups for delivering drugs |
US4096860A (en) | 1975-10-08 | 1978-06-27 | Mclaughlin William F | Dual flow encatheter |
US3995634A (en) | 1975-12-02 | 1976-12-07 | The Procter & Gamble Company | Vaginal cavity dispensing means and method |
US3995633A (en) | 1975-12-02 | 1976-12-07 | The Procter & Gamble Company | Vaginal Medicament dispensing device |
US4219426A (en) | 1976-03-19 | 1980-08-26 | Organon Teknika B.V. | Dialysis device |
US4237885A (en) | 1978-10-23 | 1980-12-09 | Alza Corporation | Delivery system with mated members for storing and releasing a plurality of beneficial agents |
US4292965A (en) | 1978-12-29 | 1981-10-06 | The Population Council, Inc. | Intravaginal ring |
DE3040978A1 (de) | 1980-10-28 | 1982-05-27 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Vaginalring |
US4484559A (en) * | 1982-03-01 | 1984-11-27 | Mcdermott Incorporated | Apparatus for removing material such as concrete from underwater pipelines |
DE3214667C2 (de) | 1982-04-21 | 1985-07-18 | Akzo Gmbh, 5600 Wuppertal | Zusammengesetzter Körper für die Langzeitabgabe von Wirkstoffen |
CA1223831A (en) | 1982-06-23 | 1987-07-07 | Dean Engelhardt | Modified nucleotides, methods of preparing and utilizing and compositions containing the same |
US4629449A (en) * | 1982-07-29 | 1986-12-16 | Alza Corporation | Vaginal dispenser for dispensing beneficial hormone |
NL8301035A (nl) | 1983-03-23 | 1984-10-16 | Organon Teknika Bv | Macromoleculair materiaal met carbonylgroepen geschikt als sorbent voor stikstofverbindingen. |
US4558996A (en) | 1983-06-30 | 1985-12-17 | Organon Teknika Corporation | Easy load peristaltic pump |
US4484599A (en) | 1983-09-23 | 1984-11-27 | Organon Teknika Corporation | Pinch-type pressure- or flow-regulating valve |
ZA857643B (en) * | 1984-10-12 | 1986-05-28 | Akzo Nv | Release system for two or more active substances |
EP0180264A1 (de) * | 1984-10-12 | 1986-05-07 | Akzo N.V. | Entladungssysteme für zwei oder mehrere aktive Substanzen |
US4645502A (en) | 1985-05-03 | 1987-02-24 | Alza Corporation | Transdermal delivery of highly ionized fat insoluble drugs |
US4762717A (en) * | 1986-03-21 | 1988-08-09 | The General Hospital Corporation | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive |
SE8602666D0 (sv) | 1986-06-16 | 1986-06-16 | Leo Ab | Intravaginal devices |
US4938759A (en) | 1986-09-02 | 1990-07-03 | Alza Corporation | Transdermal delivery device having a rate controlling adhesive |
CA1331563C (en) | 1987-08-03 | 1994-08-23 | Gaylen M. Zentner | Device for the controlled release of drugs with donnan-like modulation by charged insoluble resins |
DE3879031T2 (de) | 1987-08-08 | 1993-06-24 | Akzo Nv | Kontrazeptives implantat. |
US5474783A (en) | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
NZ228285A (en) | 1988-03-11 | 1991-08-27 | Teikoku Seiyaku Kk | Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration |
US5034229A (en) | 1988-12-13 | 1991-07-23 | Alza Corporation | Dispenser for increasing feed conversion of hog |
US5002540A (en) | 1989-05-22 | 1991-03-26 | Warren Kirschbaum | Intravaginal device and method for delivering a medicament |
US5252334A (en) | 1989-09-08 | 1993-10-12 | Cygnus Therapeutic Systems | Solid matrix system for transdermal drug delivery |
HU208495B (en) | 1990-06-27 | 1993-11-29 | Alkaloida Vegyeszeti Gyar | Process for producing retarde pharmaceutical compositions |
IE67345B1 (en) | 1991-03-12 | 1996-03-20 | Akzo Nv | Low dose dry pharmaceutical preparations |
US5211952A (en) | 1991-04-12 | 1993-05-18 | University Of Southern California | Contraceptive methods and formulations for use therein |
US5340585A (en) | 1991-04-12 | 1994-08-23 | University Of Southern California | Method and formulations for use in treating benign gynecological disorders |
US5302397A (en) * | 1991-11-19 | 1994-04-12 | Amsden Brian G | Polymer-based drug delivery system |
US6013853A (en) | 1992-02-14 | 2000-01-11 | The University Of Texas System | Continuous release polymeric implant carrier |
CA2094217A1 (en) | 1992-04-17 | 1993-10-18 | Yasutaka Igari | Transmucosal therapeutic composition |
CA2098889A1 (en) | 1992-07-06 | 1994-01-07 | Takashi Chinuki | Slow-releasing medicated resin moldings and process for producing the same |
US5482702A (en) * | 1993-04-27 | 1996-01-09 | Church & Dwight Co., Inc. | Hydrophilic polymer-coated microcrystallites of bicarbonate salt |
AU7396294A (en) | 1993-06-25 | 1995-01-24 | Alza Corporation | Incorporating poly-n-vinyl amide in a transdermal system |
GB2282384B8 (en) | 1993-08-18 | 1997-09-04 | Europ Economic Community | Drug delivery agents incorporating mitomycin |
US5543150A (en) | 1993-09-15 | 1996-08-06 | Columbia Laboratories, Inc. | Method of progesterone delivery and affect thereof |
AU692504B2 (en) | 1993-12-27 | 1998-06-11 | Akzo Nobel N.V. | Percutaneously absorbable preparation |
FR2717688B1 (fr) | 1994-03-28 | 1996-07-05 | Lhd Lab Hygiene Dietetique | Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA. |
FI97944C (fi) | 1994-07-05 | 1997-03-25 | Leiras Oy | Vaikuttavaa ainetta luovuttava laite |
US5681568A (en) | 1994-08-19 | 1997-10-28 | Cambridge Neuroscience, Inc. | Device for delivery of substances and methods of use thereof |
US5593965A (en) | 1994-10-20 | 1997-01-14 | Creighton University | Anti-tumor effects of GnRH-III |
IL116433A (en) | 1994-12-19 | 2002-02-10 | Galen Chemicals Ltd | INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS |
EP0818990A1 (de) | 1995-04-03 | 1998-01-21 | Abbott Laboratories | Homogene mischungen aus niedrigschmelzenden arzneistoffen und additiven zur verzögerten wirkstoffeingabe |
US5601839A (en) | 1995-04-26 | 1997-02-11 | Theratech, Inc. | Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
US6572879B1 (en) | 1995-06-07 | 2003-06-03 | Alza Corporation | Formulations for transdermal delivery of pergolide |
ES2166894T3 (es) * | 1995-07-04 | 2002-05-01 | Akzo Nobel Nv | Dispositivos anulares. |
FR2739032B1 (fr) | 1995-09-27 | 1997-11-21 | Lhd Lab Hygiene Dietetique | Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base d'eva, procede de preparation et utilisation en therapeutique |
US5780435A (en) | 1995-12-15 | 1998-07-14 | Praecis Pharmaceuticals Incorporated | Methods for treating prostate cancer with LHRH-R antagonists |
US6156331A (en) | 1996-02-02 | 2000-12-05 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
US5869081A (en) | 1996-06-28 | 1999-02-09 | The Population Council | Progesterone vaginal ring for treatment of infertility |
US6139873A (en) | 1996-07-10 | 2000-10-31 | Cedars-Sinai Medical Center | Combined pharmaceutical estrogen-androgen-progestin |
US5972372A (en) * | 1996-07-31 | 1999-10-26 | The Population Council, Inc. | Intravaginal rings with insertable drug-containing core |
US5945128A (en) | 1996-09-04 | 1999-08-31 | Romano Deghenghi | Process to manufacture implants containing bioactive peptides |
ATE272394T1 (de) | 1996-10-31 | 2004-08-15 | Takeda Chemical Industries Ltd | Zubereitung mit verzögerter freisetzung |
US5985861A (en) | 1996-11-04 | 1999-11-16 | Columbia Laboratories, Inc. | Progesterone for treating or reducing ischemia |
JPH10138432A (ja) | 1996-11-14 | 1998-05-26 | Teijin Ltd | 磁気テープ用二軸配向積層ポリエステルフィルム |
US5968895A (en) | 1996-12-11 | 1999-10-19 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
JPH10279499A (ja) | 1997-04-04 | 1998-10-20 | Takeda Chem Ind Ltd | 子宮粘膜適用製剤 |
IL123813A0 (en) | 1997-04-11 | 1998-10-30 | Akzo Nobel Nv | Drug delivery system for two or more active substances |
MY118835A (en) | 1997-04-18 | 2005-01-31 | Ipsen Pharma Biotech | Sustained release compositions and the process for their preparation |
US6197327B1 (en) | 1997-06-11 | 2001-03-06 | Umd, Inc. | Device and method for treatment of dysmenorrhea |
US6416779B1 (en) | 1997-06-11 | 2002-07-09 | Umd, Inc. | Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
US6572874B1 (en) | 1998-05-15 | 2003-06-03 | Umd, Inc. | Vaginal delivery of bisphosphonates |
US6905701B2 (en) | 1997-06-11 | 2005-06-14 | Umd, Inc. | Formulations for transmucosal vaginal delivery of bisphosphonates |
US6039968A (en) | 1997-06-24 | 2000-03-21 | Hoechst Marion Roussel | Intravaginal drug delivery device |
US5941844A (en) | 1997-11-17 | 1999-08-24 | Alza Corporation | Method and device for controlling mammalian reproductive cycle |
CA2316886C (en) | 1997-12-30 | 2007-09-25 | Alza Corporation | Beneficial agent delivery system with membrane plug |
USD442688S1 (en) | 1998-01-28 | 2001-05-22 | N.V. Organon | Vaginal ring applicator |
EP0940678A1 (de) | 1998-03-02 | 1999-09-08 | Akzo Nobel N.V. | Analytisches Testgerät |
US5945123A (en) | 1998-04-02 | 1999-08-31 | K-V Pharmaceutical Company | Maximizing effectiveness of substances used to improve health and well being |
ES2255266T3 (es) * | 1998-05-01 | 2006-06-16 | Duramed Pharmaceuticals, Inc. | Procedimiento de fabricacion por moldeo po inyeccion para dispositivos de liberacion controlada y dispositivo asi producido. |
US6218367B1 (en) | 1998-09-15 | 2001-04-17 | Organomed Corporation | Paclitaxel-carbohydrate conjugates: design, synthesis and biological evaluations |
US6143314A (en) | 1998-10-28 | 2000-11-07 | Atrix Laboratories, Inc. | Controlled release liquid delivery compositions with low initial drug burst |
US6159491A (en) | 1999-02-12 | 2000-12-12 | Biovector Technologies, Inc. | Prolonged release bioadhesive vaginal gel dosage form |
EP1142959A4 (de) | 1999-08-25 | 2002-11-06 | Dai Ichi Kogyo Seiyaku Co Ltd | Gelförmige gussharzzusammensetzung, verpackte flüchtige gelförmige chemikalie und deren herstellung |
US6264973B1 (en) | 1999-08-26 | 2001-07-24 | Fei Enterprises, Ltd. | Apparatus and method for anesthetizing the cervical region of a female |
WO2001026648A1 (fr) | 1999-10-13 | 2001-04-19 | Senju Pharmaceutical Co., Ltd. | Preparation d'adhesif a usage ophtalmique pour l'absorption par voie percutanee |
US6264981B1 (en) | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
GB0102342D0 (en) * | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
US6687178B1 (en) * | 2001-02-23 | 2004-02-03 | Western Digital (Fremont), Inc. | Temperature dependent write current source for magnetic tunnel junction MRAM |
-
2004
- 2004-04-29 AT AT04760436T patent/ATE461681T1/de not_active IP Right Cessation
- 2004-04-29 CA CA2523859A patent/CA2523859C/en not_active Expired - Lifetime
- 2004-04-29 US US10/835,414 patent/US7833545B2/en active Active
- 2004-04-29 JP JP2006513416A patent/JP4898431B2/ja not_active Expired - Lifetime
- 2004-04-29 DE DE602004026173T patent/DE602004026173D1/de active Active
- 2004-04-29 EP EP04760436A patent/EP1620060B1/de not_active Expired - Lifetime
- 2004-04-29 WO PCT/US2004/013172 patent/WO2004096151A2/en active Application Filing
- 2004-04-29 AU AU2004233997A patent/AU2004233997C1/en active Active
-
2008
- 2008-05-22 US US12/125,593 patent/US7829112B2/en active Active
- 2008-05-22 US US12/125,571 patent/US7838024B2/en not_active Expired - Lifetime
- 2008-05-22 US US12/125,606 patent/US20080286339A1/en not_active Abandoned
- 2008-05-22 US US12/125,581 patent/US7883718B2/en active Active
- 2008-05-22 US US12/125,629 patent/US20090060982A1/en not_active Abandoned
-
2011
- 2011-01-14 US US13/007,222 patent/US20120202742A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20070196433A1 (en) | 2007-08-23 |
JP4898431B2 (ja) | 2012-03-14 |
WO2004096151A3 (en) | 2006-05-11 |
EP1620060B1 (de) | 2010-03-24 |
EP1620060A4 (de) | 2007-11-28 |
WO2004096151A2 (en) | 2004-11-11 |
US20090060982A1 (en) | 2009-03-05 |
AU2004233997B9 (en) | 2013-01-10 |
AU2004233997B8 (en) | 2010-01-14 |
US7838024B2 (en) | 2010-11-23 |
US20090274654A1 (en) | 2009-11-05 |
AU2004233997A1 (en) | 2004-11-11 |
ATE461681T1 (de) | 2010-04-15 |
US20080286322A1 (en) | 2008-11-20 |
CA2523859A1 (en) | 2004-11-11 |
CA2523859C (en) | 2011-08-02 |
US7883718B2 (en) | 2011-02-08 |
US20080286339A1 (en) | 2008-11-20 |
JP2007525461A (ja) | 2007-09-06 |
US20080248017A1 (en) | 2008-10-09 |
US7829112B2 (en) | 2010-11-09 |
US7833545B2 (en) | 2010-11-16 |
AU2004233997B2 (en) | 2009-12-17 |
EP1620060A2 (de) | 2006-02-01 |
US20120202742A1 (en) | 2012-08-09 |
AU2004233997C1 (en) | 2014-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004026173D1 (de) | Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln | |
MXPA05008648A (es) | Usos y formulaciones para la aplicacion transdermica o transmucosa de agentes activos. | |
MA27586A1 (fr) | Systemes de distribution pharmaceutiques et/ou cosmetiques topiques | |
NO993520L (no) | Doseringsformer og fremgangsmÕte for Õ bedre erektil dysfunksjon | |
UY27532A1 (es) | Forma de dosificación de liberación controlada dual. | |
ATE450252T1 (de) | Arzneimittel-mikroteilchen | |
TW200505402A (en) | Ophthalmic drug delivery device | |
TW200642704A (en) | Oral drug delivery system and methods of use thereof | |
MXPA03010991A (es) | Composicion permeable a la piel que comprende inhibidor de ciclooxigenasa-a selectivo y alcohol monohidrico. | |
EP1429729A4 (de) | Kombinierte dosierform mit einem cholesterinsenker, einem renin-angiotensin-hemmer und acetylsalicylsäure | |
TW200605915A (en) | Drug delivery compositions | |
SG159559A1 (en) | Pharmaceutical product | |
AR033042A1 (es) | Terapia de reemplazo hormonal | |
TW200509998A (en) | Controlled release of highly soluble agents | |
AU2357202A (en) | Ion-strength independent sustained release pharmaceutical formulation | |
AR008886A1 (es) | Uso de un inhibidor h+,k+-atpasa en la fabricacion de un medicamento para el tratamiento de polipos nasales, del sindrome de widal, uso de dicho inhibidor y un glucocorticoide para la fabricacion de una formulacion farmaceutica y formulacion farmaceutica para administracion simultanea | |
AR034142A1 (es) | Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion | |
DE60207693D1 (de) | Einweg-vaginalkanüle für die gleichzeitige verabreichung von arzneimitteln in verschiedener form | |
ATE310539T1 (de) | Artikel zur wundbehandlung | |
DE502005002624D1 (de) | Nahrungsergänzungsmittelabgabevorrichtung | |
AR027677A1 (es) | Una composicion farmaceutica terapeutica que comprende camptotecina y ciclofosfamida para el tratamiento del cancer | |
UY27857A1 (es) | Medicamento para el tratamiento del "síndrome de respuesta inflamatoria sistémica" | |
PT1499278E (pt) | Forma de dosagem farmaceutica de libertacao imediata compreendendo tibolona polimorfa | |
WO2007016146A3 (en) | Method for retarding systemic delivery rate for easily absorbable active agents | |
WO2005011589A3 (en) | Drug delivery methods and devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |